These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 31713283)

  • 1. Differential effect of interferon-alpha treatment on AEA and 2-AG levels.
    Zajkowska Z; Borsini A; Nikkheslat N; Russell A; Romano GF; Tomassi S; Hepgul N; Forton D; Agarwal K; Hotopf M; Mondelli V; Zunszain P; Pariante CM
    Brain Behav Immun; 2020 Nov; 90():248-258. PubMed ID: 32860939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocannabinoids and Stress-Related Neurospsychiatric Disorders: A Systematic Review and Meta-Analysis of Basal Concentrations and Response to Acute Psychosocial Stress.
    Gowatch LC; Evanski JM; Ely SL; Zundel CG; Bhogal A; Carpenter C; Shampine MM; O'Mara E; Mazurka R; Barcelona J; Mayo LM; Marusak HA
    Cannabis Cannabinoid Res; 2024 Apr; ():. PubMed ID: 38683635
    [No Abstract]   [Full Text] [Related]  

  • 3. The relationship between cannabis and anorexia nervosa: a scoping review.
    Rogers CI; Pacanowski CR
    J Eat Disord; 2023 Oct; 11(1):186. PubMed ID: 37858278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of anandamide and 2-arachidonoylglycerol concentrations with clinical features and body mass index in eating disorders and obesity.
    Baenas I; Miranda-Olivos R; Granero R; Solé-Morata N; Sánchez I; Pastor A; Del Pino-Gutiérrez A; Codina E; Tinahones FJ; Fernández-Formoso JA; Vilarrasa N; Guerrero-Pérez F; Lopez-Urdiales R; Virgili N; Soriano-Mas C; Jiménez-Murcia S; de la Torre R; Fernández-Aranda F
    Eur Psychiatry; 2023 May; 66(1):e49. PubMed ID: 37254556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders.
    Navarro D; Gasparyan A; Navarrete F; Torregrosa AB; Rubio G; Marín-Mayor M; Acosta GB; Garcia-Gutiérrez MS; Manzanares J
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin, ghrelin, and endocannabinoids: potential therapeutic targets in anorexia nervosa.
    Støving RK; Andries A; Brixen K; Flyvbjerg A; Hørder K; Frystyk J
    J Psychiatr Res; 2009 Apr; 43(7):671-9. PubMed ID: 18926548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deranged endocannabinoid responses to hedonic eating in underweight and recently weight-restored patients with anorexia nervosa.
    Monteleone AM; Di Marzo V; Aveta T; Piscitelli F; Dalle Grave R; Scognamiglio P; El Ghoch M; Calugi S; Monteleone P; Maj M
    Am J Clin Nutr; 2015 Feb; 101(2):262-9. PubMed ID: 25646322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa.
    Monteleone P; Matias I; Martiadis V; De Petrocellis L; Maj M; Di Marzo V
    Neuropsychopharmacology; 2005 Jun; 30(6):1216-21. PubMed ID: 15841111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women.
    Pastor A; Fernández-Aranda F; Fitó M; Jiménez-Murcia S; Botella C; Fernández-Real JM; Frühbeck G; Tinahones FJ; Fagundo AB; Rodriguez J; Agüera Z; Langohr K; Casanueva FF; de la Torre R
    PLoS One; 2016; 11(2):e0148734. PubMed ID: 26849214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa.
    Collu R; Scherma M; Piscitelli F; Giunti E; Satta V; Castelli MP; Verde R; Fratta W; Bisogno T; Fadda P
    Int J Eat Disord; 2019 Nov; 52(11):1251-1262. PubMed ID: 31456239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the influence of circulating endocannabinoids and nucleus accumbens functional connectivity on anorexia nervosa severity.
    Miranda-Olivos R; Baenas I; Steward T; Granero R; Pastor A; Sánchez I; Juaneda-Seguí A; Del Pino-Gutiérrez A; Fernández-Formoso JA; Vilarrasa N; Guerrero-Pérez F; Virgili N; López-Urdiales R; Jiménez-Murcia S; de la Torre R; Soriano-Mas C; Fernández-Aranda F
    Mol Psychiatry; 2023 Nov; 28(11):4793-4800. PubMed ID: 37759041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered circulating endocannabinoids in anorexia nervosa during acute and weight-restored phases: A pilot study.
    Piccolo M; Claussen MC; Bluemel S; Schumacher S; Cronin A; Fried M; Goetze O; Martin-Soelch C; Milos G
    Eur Eat Disord Rev; 2020 Jan; 28(1):46-54. PubMed ID: 31713283
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.